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Abstract: Intraoperative 5- aminolevulinic acid induced-Protoporphyrin IX 
(PpIX) fluorescence guidance enables maximum safe resection of 
glioblastomas by providing surgeons with real-time tumor optical contrast. 
However, visual assessment of PpIX fluorescence is subjective and limited 
by the distorting effects of light attenuation and tissue autofluorescence. We 
have previously shown that non-invasive point measurements of absolute 
PpIX concentration identifies residual tumor that is otherwise non-
detectable. Here, we extend this approach to wide-field quantitative 
fluorescence imaging by implementing spatial frequency domain imaging 
to recover tissue optical properties across the field-of-view in phantoms and 
ex vivo tissue. 
© 2015 Optical Society of America 
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1. Introduction 
The extent of resection of glioma is a significant prognostic factor [1]. Specifically, complete 
or near-complete tumor resection, removing >98% of the gadolinium-enhancing tumor seen 
on MRI, increases patient survival and improves the efficacy of adjuvant radiotherapy and 
chemotherapy [1]. 5-aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence 
guided resection (PpIX-FGR) helps define tumor margins without disrupting the surgical 
work flow [2]. 5-ALA is administered orally at~3h prior to surgery. After removing the bulk 
tumor, the surgical field is illuminated with violet-blue light, whereupon residual tumor tissue 
is visualized by the red PpIX fluorescence. PpIX-FGR has shown increased complete 
resection rates (65% vs. 36%) and prolonged progression-free survival (16.7 vs. 11.8 months) 
[3]. However, the technique remains qualitative and subjective. 
Since tissue is highly scattering, the measured fluorescence signal at the tissue surface is 
distorted, depending on the wavelength-dependent reduced scattering coefficient, 'sμ and 
absorption coefficient, aμ , at the excitation and emission wavelengths. This results in loss of 
sensitivity to detect residual tumor [4]. The PpIX fluorescence signal is also seen on a 
background of tissue autofluorescence [5]. These confounding factors limit the sensitivity of 
direct visual fluorescence guidance [6]. We have shown that quantitative assessment of the 
true fluorophore concentration, [PpIX], can improve residual tumor detection [6] using a 
contact fiber-optic probe that measures both the tissue fluorescence and diffuse reflectance 
spectra at two source-detector separations. Applying a spectrally-constrained diffusion model, 
the intrinsic optical properties are uncoupled from the fluorescence signal, yielding absolute 
measurement of [PpIX] with an accuracy of ± 10% down to ~10 ng/g. Ongoing clinical trials 
have demonstrated increased sensitivity and specificity for high-grade glioma and extension 
of FGR to low-grade disease [6]. However, this quantitative fluorescence spectroscopy (qFS) 
technique samples the resection surface only point-by-point. Hence, we are pursuing several 
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approaches to wide-field quantitative fluorescence imaging, qFI [7]. One approach uses a 
semi-empirical ratiometric correction algorithm based on hyperspectral florescence and 
diffuse reflectance imaging [7]. Here we present the first results of a more rigorous, model-
based algorithm using spatial frequency domain imaging (SFDI) in diffuse reflectance mode 
to map the wavelength-dependent tissue optical properties, which are then applied on a pixel-
by-pixel basis to correct the measured fluorescence image. 
SFDI determines aμ and 'sμ  as 2D maps by projecting sinusoidal patterns of different 
spatial frequencies onto the tissue surface [8], which acts as a low-pass filter. The degree of 
blurring at a given spatial frequency depends on the tissue optical properties, as well as the 
modulation transfer function of the illumination-detection system. After compensating for the 
latter, a standard diffusion theory approximation (SDA) or a Monte Carlo (MC)-based look-
up table (LUT) is then used to solve the inverse problem and extract the optical properties. 
The system uses multi-wavelength excitation and a liquid crystal tunable filter (LCTF) 
coupled to a 14-bit CCD, enabling hyperspectral SFDI. The system integrates quantitative 
diffuse reflectance imaging and hyperspectral fluorescence imaging to produce quantitative 
maps of [PpIX]. While others have used multi-wavelength SFDI to correct fluorescence 
images in the visible domain [9] or to obtain near-infrared chromophore concentrations [10], 
we have extended SFDI to extract optical properties in both the diffusive and sub-diffusive 
regime, where the transport albedo, 'a  = 'sμ /( aμ  + 'sμ ), can be as low as 0.2 in glioma at 
405 nm [4]. Here we report the capability to recover tissue optical properties in these regimes 
and then apply the qFI model to obtain quantitative fluorescence images in both tissue-
simulating phantoms and ex vivo tissues. Finally, the derived [PpIX] values are compared to 
those measured by the “gold standard” of qFS. 
2. Methodology 
2.1 SFDI system and experimental setup 
The SFD-enabled qFI system is shown in Fig. 1. The DLP light engine (0.55XGA Series 450 
DMD, Texas Instruments, Dallas, Tx) was customized for this application. The standard DLP 
white light source was replaced by 6 LEDs (Spectra X, Lumencor, Beaverton, OR) at 390, 
438, 475, 512, 586 and 632 nm. The light is focused onto the micromirror array by a 3 mm 
liquid light guide (LGG0338, ThorLabs, Montreal, Canada). Specular reflection is limited by 
illuminating slightly off normal incidence. In front of the 14-bit CCD (Pixelfly, PCO AG, 
Kelheim, Germany), a C-mount lens couples the CCD to the visible-range liquid crystal 
tunable filter (LCTF: varispec-07-02, Perkin Elmer. Inc, Waltham, MA). The 20 cm working 
distance and 4x4 cm field-of-view approximate the neurosurgical microscope. 
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Fig. 1. (a) Photograph of the SFDI qFI system; (b) corresponding schematic with the liquid 
light guide (LGG), digital micromirror device (DMD), lenses (L1, L2), mirror (M1), liquid 
crystal tunable filter (LCTF), charge-coupled device (CCD) and the sample stage. 
2.2 SFDI implementation 
In SFDI, the structured light patterns illuminating the surgical field are sinusoids of the form: 
 0 0 .cos(2 xS S A f xπ ϕ)= + +  (1) 
, where 0S is the illumination source intensity, xf is the spatial frequency, 0A is the modulation 
depth and ϕ is the spatial phase. The diffuse reflected intensity image is also a superposition 
of spatially modulated illumination ( ACI ) and planar illumination ( DCI ), where ACI has the 
form: 
 ( , ) ( , ).cos(2 )AC x AC x x iI x f M x f f xπ ϕ= +  (2) 




π πϕ = . We choose to recover ACM by 




and applying a time-domain 
amplitude demodulation scheme over applying the Hilbert transform on a single phase 
intensity image, because the Hilbert transform results in poor image quality from ringing 
effects in the frequency domain [8]: 
 
2 2 2
1 2 1 3 2 32 {[ ( ) ( )] [ ( ) ( )] [ ( ) ( )] }( , )
3AC i x
I x I x I x I x I x I x
M x f
× − + − + −
=  (3) 
, while the DC reflectance amplitude, DCM , is obtained from the average of three phase-
shifted images for the same xf : 
 1 2 3





I x I x I x
M x
+ +
=  (4) 
The calibrated demodulated reflectance, dR is formed from the ratio of the demodulated 
intensity measured on the sample, ,sampleACM  to that on a reference standard of known optical 
properties, ,refACM multiplied by the diffuse reflectance, 
ref
dR , of the standard: 
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2.3 Quantitative reflectance imaging 
While most studies have applied SFDI in the near- infrared with SDA as the light transport 
model [8,11], MC-based LUTs have also been constructed for the visible range where the 
diffusion model starts to break down [12,13]. Since the reported tissue optical properties in 
glioma ( aμ ~3 mm
−1 and 'sμ ~1 mm
−1) at the excitation wavelength are in the sub-diffusive 
regime [4], MC is the more appropriate model. However, we present optical properties in the 
diffusive regime as well as the sub-diffusive regime derived by SDA only, because our 
previous results show that SDA derived optical properties in the sub-diffusive regime better 
compare to their expected values with a relative error similar to those reported for 
scattering dominant tissue-like phantoms [14]. 
2.3.1 Diffusive regime 
To validate the performance of the system, three liquid phantoms were made from 20% 
Intralipid (Fresenius Kabi, Sweden) as the scatterer and India ink as the absorber, varying the 
concentrations to produce aμ and 'sμ values similar to glioma at the PpIX fluorescence 
emission peak ~635 nm as exemplified in Table 1 and reported in [4]. The phantoms were 
imaged at 632 nm for fx between 0 and 1.7 mm
−1, each for 25 ms integration time. The 
modulated images were collected with the LCTF set to 640 nm. Eqs. (3), (4), (5) were applied 
to generate images dR (fx). For each pixel, these measurements were then fitted to the 
spatially-resolved diffuse reflectance predicted by SDA in the frequency domain [8]. Each 
measurement was repeated in triplicate. 
2.3.2 Sub-diffusive regime 
Since we are interested in extracting maps of aμ and 'sμ at the PpIX excitation wavelength of 
405 nm, SFDI will be implemented on absorption-dominant tissue, where the diffusion model 
is expected to break down ( 'sμ / aμ <3) [8]. In addition, the source-detector separation for 
diffusive conditions should be > 3/ 'sμ , which corresponds to fx< 0.33( 'sμ  + aμ ). Although 
'sμ  < aμ at 405 nm, we justify the use of SDA to recover both the optical properties by 
extending the SFDI frequency up to 1.7 mm−1, thereby still satisfying the condition fx< 0.33 
trμ . Using higher spatial frequencies is particularly useful in the sub-diffusive domain, since 
it better separates the effects of tissue absorption from scattering on the modulated reflectance 
image. This is because higher absorption causes the diffuse reflectance to attenuate more 
slowly with spatial frequency. Therefore, the upper limit, while still satisfying the above 
condition, is chosen by determining the spatial frequency that reduces dR (fx) to half its 
maximum value ( dR (fx = 0)) for a given range of aμ  and 'sμ . Here the average aμ  and 
'sμ values in the sub-diffusive regime are 4 and 2 mm
−1, respectively, so that ( 0) / 2d xR f = is 
around 1.7 mm−1. In principle, projecting higher spatial frequencies is possible because higher 
aμ  retains the higher frequency patterns, thus keeping the modulated signal above 
background noise. 
In order to simulate tissue absorption at 405 nm, yellow food dye was added at varying 
concentrations producing optical properties with 'a  from 0.2 to 0.6. The same spatial 
frequencies as above were used and ( )AC xM f  were collected from 420 to 720 nm. The raw 
images were sharper than the first set of phantoms but required a longer acquisition time of 
100 ms to achieve comparable signal-to-noise. The reference Intralipid–dye phantom had 
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aμ and 'sμ both equal to 1 mm
−1. The true aμ values were obtained from a spectrophotometer 
with a standard error of ± 2%. The expected 'sμ  value was derived empirically by Michels et 
al. and had a 2-4% uncertainty for a given Intralipid batch [15]. 
2.4 Quantitative Fluorescence Imaging 
2.4.1 Fluorescence model 
Recovering the true [PpIX] distribution is equivalent to accurately measuring the intrinsic 
PpIX fluorescence intensity, ,x mqf , defined as: 
 , , , , ,. . .[ ],x m x m af x x m x mqf Q Q PpIXμ ε= =  (6) 
where ,x mQ , ,af xμ  and ,x mε are, respectively, the PpIX fluorescent quantum yield, wavelength-
dependent absorption coefficient and extinction coefficient. Subscripts x and m refers to the 
excitation and emission wavelengths. Hence, measuring ,x mqf and knowing 
,x mQ and ,x mε should yield [PpIX]. However, due to light scattering, the detected fluorescence 
is not the true fluorescence and is modulated by tissue’s absorption and scattering coefficients 
at both the excitation and emission wavelength. For excitation at 400-440 nm, where the PpIX 
and hemoglobin absorption are high, the remitted fluorescent photons, mF , detected at 600-
720 nm can be assumed to travel similar path lengths to those for the diffuse reflectance 
signal, mR , in the same wavelength range. Hence, mF is proportional to mR multiplied by the 
fraction of excitation photons absorbed by PpIX and producing fluorescence. Thus [16], 
 ,
,
.(1 ). ( )








=  (7) 
where txR is the predicted total diffuse reflectance at the excitation wavelength and mR is the 
measured wavelength-dependent diffuse reflectance at the emission band 600-720 nm. ,a xμ is 
obtained by fitting the measured txR to the predicted SDA-based spatially-
resolved ( , )xR rλ with the spectral shapes of ,a xμ and 'sxμ  as constraints. Rearranging to solve 
for wide field ,x mqf , the model becomes: 
 ,, , ,
. ( )
. ,
(1 ). ( )
a x m











where mR and xR are the demodulated diffuse reflectance values. 
In addition to producing a 2D map of ,a xμ , SFDI produces the demodulated and calibrated 
total diffuse reflectance images xR and mR  using Eq. (5) as input to the modified qF model: 
 ,,
( , ). ( , . )
( , , )




x y F x y
qf x y







xR and mR are then the average of the DC reflectance images (see Eqs. (4,5) calculated for all 
frequencies. 
2.4.2 Phantom studies 
In fluorescence mode, the SFDI system projects a violet-blue uniform field (fx = 0). The raw 
fluorescence is captured from 600 to 720 nm in steps of 10 nm. The acquisition time varies 
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from 0.5 to 2s depending on the optical properties. In reflectance mode, SFDI was 
implemented in both the violet-blue and red bands. The reflectance images from 420 to 720 
nm were collected for 100 ms per wavelength. 
PpIX (Sigma-Aldridge) was dissolved at 5µg/ml in dimethyl sulfoxide (DMSO), this 
being representative of the PpIX tissue concentration in high-grade glioma [4]. This was 
mixed with Intralipid and yellow dye of different concentrations to simulate tissue absorption 
at 405 nm. The resulting phantoms had 'a  = 0.2 to 0.6 with absorption coefficients as high as 
6 mm−1, as summarized in Table 1. One phantom was used as the reference. The raw 
fluorescence and reflectance images were flat-field corrected and the modified qF model was 
applied using Eq. (9). qfx,m(λ) was scaled using the published PpIX fluorescence quantum 
yield of 0.5% [17]. As an additional comparison, the flat-field corrected fluorescence images 
were also normalized to the demodulated diffuse reflectance, Rx, to evaluate the performance 
of correcting the fluorescence images simply by the common Born normalization method. 
Table 1. Summary of phantom optical properties used to test the qFI model in order of 






6.0 1.5 0.20 
6.0 2.0 0.25 
4.0 1.5 0.27 
4.0 2.0 0.33 
1.4 1.0 0.41 
2.0 1.5 0.42 
3.0 2.3 0.43 
2.0 2.3 0.54 
2.4.3 Ex vivo tissue studies 
As an intermediate step towards in vivo qFI, we used a tissue model comprising ground beef 
or chicken in a 3 cm deep petri dish. The center portion was mixed with 1.0 µg/ml and 3.0 
µg/ml of PpIX in the chicken and beef, respectively. Polarizing filters were added to the 
illumination and detection to further limit specular reflection. Planar fluorescence images 
were collected from 600 to 720 nm and SFD images from 420 to 720 nm at fx = 0-1.49 mm
−1. 
For SFDI analysis, two regions were selected per sample: the PpIX-rich central zone region 
and the PpIX-free surrounding zone. The recovered aμ and 'sxμ 2D maps were used as inputs 
to the qFI model. [PpIX] was then calculated from the quantitative hyperspectral fluorescence 
images using the known basis spectrum and the built-in Matlab function lsqnonneg for 
nonnegative least-squares curve fitting. Since no significant autofluorescence was detected, 
PpIX and its photoproducts were considered as the only fluorophores. As an independent 
method, tissue was also sampled with the qFS probe. 
3. Results and discussion 
3.1 Quantitative reflectance imaging 
3.1.1 Diffusive regime 
The known and recovered optical coefficients are shown in Table 2. The average standard 
deviation for each measurement performed in triplicate and normalized to the mean was ± 
1.1%. These measurements were made on the same phantom at different times within 2 days. 
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The expected error in preparing a new set of phantoms from Intralipid and India ink is 
estimated to be ± 2% [18]. 
Table2. Accuracy in recovering phantom optical properties in the diffusive regime at 635 
nm 
True aμ (mm−1) True 'sxμ  (mm−1) SDA-derived 
aμ (mm−1) (COVa) 
SDA-derived 
'sxμ  (mm−1) 
(COV) 
RMS 
0.002 0.87 0.0021 (5%) 0.89 (2%) 3.8% 
0.004 1.14 0.0043 (7.5%) 1.19 (5%) 6.4% 
0.006 1.42 0.0059 (1.7%) 1.34 (5%) 3.7% 
aCOV: coefficient of determination, relative difference between the true and SFDI-derived values. RMS: root 
mean square error 
3.1.2 Sub-diffusive regime 
Table 3 summarizes the results for recovering optical properties in the sub-diffusive regime. 
The combined RMS error increased from 5% for 'a  = 0.5 to 30% for 'a  = 0.3, attributed to 
the increasing breakdown of SDA. Interestingly, the average error in recovering 'sμ is twice as 
high as that in recovering aμ probably due to the uncertainty in the true scattering coefficient. 
Nevertheless, there is a systemic increase in the error when a ' <0.35. While in principle, 
Monte Carlo simulations should be used for solving in the sub-diffusive domain, we have 
shown that SDA-derived optical properties have a relative error similar to that reported 
for scattering-dominant phantoms [14]. This may be due to selecting a standard phantom 
with properties also in the sub-diffusive regime as well as sampling at higher spatial 
frequencies. Table3. Accuracy in recovering phantom optical properties in the sub-diffusive regime 





2.00 1.50 2.13 (6.5%) 1.25 (17%) 12.9 
2.00 2.00 2.15 (7.5%) 2.07 (3.5%) 5.85 
2.00 2.50 2.05 (2.5%) 2.29 (8.4%) 6.20 
4.00 1.50 4.47 (12%) 1.28 (15%) 13.6 
4.00 2.00 3.60 (10%) 1.91(4.5%) 7.75 
4.00 3.37 3.79 (5.3%) 3.22 (4.5%) 4.92 
6.00 1.50 4.67 (22%) 1.09 (27%) 24.6 
6.00 2.00 5.90 (1.7%) 1.38 (31%) 22.0 
6.00 2.50 5.45 (9.2%) 1.46 (42%) 30.4 
3.2 Quantitative fluorescence imaging 
Figure 2(a) demonstrates the strong dependence of the raw fluorescence images on the optical 
properties. Figure 2(b) shows that the derived images have more constant intensity when qFI 
is applied, but with some overestimate for the lowest albedo phantom. Figure 2(c) shows the 
variation in the quantitative fluorescence images, plotting the mean intensities (and 
corresponding standard deviations) from each phantom shown in 2(b) after normalization to 
the mean fluorescent intensity across all eight phantoms. The standard deviation for each 
phantom indicates small variations in the derived fluorescence across the whole image. The 
mean relative standard deviations from all eight phantoms are summarized in Table 4. Simply 
normalizing the measured fluorescence images to the reflectance images reduces the variance 
from 108% to 36% but applying the qFI model gives a much greater (6-7 fold) reduction. The 
largest error in the SFDI-derived aμ values also corresponds to the lowest albedo case, 
suggesting that the modified qFI model still has a residual ( 15%≈ ) dependence on the tissue 
optical properties, which deteriorates for very low albedos. The relative standard deviation in 
[PpIX] for similar optical properties is 10%≈ when qFS is used [16]. 
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Table 4. Comparison of the relative and maximum standard deviation values for the 
PpIX phantoms, normalized to the mean in each case, using 3 different algorithms 
Correction method Relative standard deviation (%) Maximum standard deviation (%)
Measured fluorescence 107 303 
Born-normalized fluorescencea 35.7 102 
qFI 15.4 24.2 
qFSb 10.1 15.2 
a Based on the calibrated SFDI-derived reflectance obtained from Eq. (4) and Eq. (5) 
bUsing the qFS point probe system.
Fig. 2. (a) Raw fluorescence images for tissue phantoms with [PpIX] = 5µg/ml; (b) Derived 
fluorescence images after applying the qFI model. The phantom optical properties are shown 
in Table 1 and the images are displayed in order of increasing transport coefficient, µTR, (c) 
Corresponding plot of the mean quantitative fluorescent intensity of each image normalized to 
the mean fluorescent intensity. The error bars denote the standard deviation across each image 
relative to its mean intensity. 
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Figures 3(a), 3(b) show the raw PpIX fluorescence image and the model-corrected 
fluorescence image from the chicken tissue sample detected at 640 nm. It is recognized that 
these ex vivo model tissues likely do not have the identical optical properties as glioma and 
normal brain tissue and in particular are likely less scattering. However, they are still highly 
diffusive, and so provide a reasonable proof-of-principle test of the correction algorithm. 
Indeed, the corrected fluorescence image does show a larger extent of PpIX signal compared 
to the raw fluorescence image, and this corresponds to the real situation. It is also known that 
the spatial distribution of PpIX near the tumor margin is not necessarily sharply defined, as it 
is in the model used here, since gliomas tend to be infiltrative. However, this should not 
markedly affect the accuracy of the correction algorithm. 
Table 5 compares the mean values for tissue optical properties and the derived [PpIX] 
values obtained by applying the qFI to the same parameters obtained by the qFS probe. 
The 'a value of (white) chicken tissue was measured as less than that of the more pigmented 
ground beef, which should not be the case. This is likely due to altered scattering properties 
due to the different tissue handling prior to measurements (frozen & thawed versus fresh, 
resp.). Marked effects on scattering by freeze/thaw have been reported elsewhere [19]. The 
mean [PpIX] derived by qFI for each sample correlates well with the true value (within 20%), 
as well as with that derived from qFS. 
As regards to sensitivity, preliminary data suggest that [PpIX] down to ~20 ng/g in tissues 
with aμ as high as 8.8 mm
−1 can be measured, but the uncertainty in this is yet to be 
determined. Clinically, [PpIX] found in biopsy sampled glioma patients varied from 3.6 to 
4523 ng/g for tumor grades 1 to 4, respectively [6]. Hence, although we expect the sensitivity 
of the intraoperative probe (10 ng/g) to be superior to that of SFD-based wide-field qF 
imaging, a sensitivity of 20 ng/g is still clinically relevant for higher-grade patients. 
Additionally, the sensitivity of the semi-empirical ratiometric approach is reported to be 100 
ng/ml ± 10% when the same CCD presented here is used [7]. This sensitivity is reduced to 20 
ng/ml ± 20% when a CMOS based camera is used [7]. The lower limit for detecting and 
quantifying the PpIX concentration in tissue will also be affected by the level of tissue 
autfluorescence. Ongoing work includes evaluating the accuracy of qFI to estimate [PpIX] in 
vivo using an intracranial tumor-bearing rat model. Our previous semi-empirical quantitative 
fluorescence imaging studies have shown that the corrected fluorescence spectrum can be 
spectrally decomposed into the contributions from PpIX, PpIX photoproducts (generated 
during surgical exposure of the tissue) and tissue autofluroescence, and this approach should 
be equally valid using the correction algorithms developed here [7]. 
 
Fig. 3. (a) Raw fluorescence image at 640 nm for the chicken sample with [PpIX] = 1µg/ml; 
(b) Derived fluorescence images after applying the qFI model. 
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Table 5. Comparison of SFD-qFI derived optical properties (mm−1) and [PpIX] (µg/ml) 
with those derived by qFS. The known [PpIX] added to chicken and beef were 1.0 µg/l 
and 3.0 µg/l 
Tissue qFI 
a
a stdμ ±  
's stdμ ±  [PpIX] std±  
qFS 
a stdμ ±  
's stdμ ±  [PpIX] std±  
chicken 0.74 ± 0.17 0.74 ± 0.09 0.81 ± 0.02 0.81 ± 0.27 1.11 ± 0.04 0.99 ± 0.37 
beef 1.43 ± 0.19 1.21 ± 0.42 2.56 ± 0.30 1.25 ± 0.38 1.36 ± 0.76 2.56 ± 0.21 
astd is the standard deviation in the recovered optical parameters and [PpIX] across the region of interest in Fig. 3 
4. Conclusions 
In summary, the performance of a novel multi-wavelength, spectrally-resolved SFD-based 
system for quantitative wide-field fluorescence imaging has been evaluated in tissue-
simulating phantoms and in an ex vivo tissue model. This is an extension to the current point 
qFS probe that is in clinical trials and an alternative to our previously-reported semi-empirical 
ratiometric technique [7]. The transport albedo range of the tissue optical properties tested 
spans the diffusive as well as the sub-diffuse regime. The errors (2-30%) in the SDA-derived 
optical properties in the sub-diffusive regime are within the range of errors reported by SDA-
derived optical properties in the diffusive regime when compared to MC [8]. This was made 
possible by calibrating the system with a standard of similar albedo, as well as sampling at 
higher spatial frequencies to better separate absorption and scattering. 
As for the fluorescence model, the relative standard deviation of the corrected 
fluorescence images across a wide range of tissue phantom optical properties (Table 1) 
compares well with that evaluated by qFS (15% vs. 10%). [PpIX] values derived by SFD-qFI 
from ex vivo tissue are within 20% the absolute [PpIX]. This is compared to the calculated 
[PpIX] from qFS, which are within 14% of the true [PpIX]. Even though current acquisition 
times do not allow for real-time imaging and analysis, video-rate imaging should be possible 
after automating the sequence for patterned illumination and optimizing the inverse solver. 
Additionally, substituting the CCD with a CMOS based camera may not only improve the 
accuracy and sensitivity of quantifying fluorescence images as discussed above, but will 
significantly reduce acquisition times. Moreover, a replica of this benchtop SFDI system is 
being modified to mount on a surgical microscope for first clinical trials in glioma surgery 
[20]. Finally, structured-light profilometry via the SFDI system is being implemented to 
account for the curved surface of the tumor resection bed at craniotomy [20]. 
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